コンテンツへスキップ
Merck
  • Synergic effect of exercise and lipoic acid on protection against kainic acid induced seizure activity and oxidative stress in mice.

Synergic effect of exercise and lipoic acid on protection against kainic acid induced seizure activity and oxidative stress in mice.

Neurochemical research (2014-06-06)
Hee-jae Kim, Wook Song, Jin-Soo Kim, Eun Hee Jin, Moon-Seok Kwon, Sok Park
要旨

Anti-convulsant effects of physical exercise and lipoic acid (LA), also referred to as thioctic acid with antioxidant activity, were investigated using chemical induced seizure model. We investigated the synergic effect of physical exercise and LA on kainic acid-induced seizure activity caused by oxidative stress. After 8 weeks of swimming training, body weight decreased and endurance capacity increased significantly compared to sedentary mice. Kainic acid (30 mg/kg, i.p.) evoked seizure activity 5 min after injection, and seizure activity peaked approximately 80 min after kainic acid treatment. Median seizure activity score in KA only treated group was 4.55 (range 0.5-5), 3.45 for "LA + KA" group (range 0.5-4.3), 3.12 for "EX + KA" group (range 0.05-3.4, p < 0.05 vs. "KA only" group), 2.13 for "EX + LA + KA" group (range 0.5-3.0, p < 0.05 vs. "EX + KA" group). Also, there was a synergic cooperation of exercise and LA in lowering the mortality in kainic acid treated mice (χ2 = 5.45, p = 0.031; "EX + KA" group vs. "LA + EX + KA" group). In addition, the synergic effect of exercise and LA was found in PGx activity compared to separated treatment ("LA + EX + KA": 37.3 ± 1.36; p < 0.05 vs. "LA + KA" and "EX + KA" group). These results indicate that physical exercise along with LA could be a more efficient method for modulating seizure activity and oxidative stress.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(±)-α-リポ酸, ≥98.0%
Sigma-Aldrich
(±)-α-リポ酸, suitable for cell culture, BioReagent, ≥99%
Sigma-Aldrich
(±)-α-リポ酸, synthetic, ≥99% (titration), powder
USP
(±)-α-リポ酸, United States Pharmacopeia (USP) Reference Standard
(±)-α-リポ酸, European Pharmacopoeia (EP) Reference Standard
(±)-α-リポ酸, European Pharmacopoeia (EP) Reference Standard
システム適合性用チオクト酸, European Pharmacopoeia (EP) Reference Standard